Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, sold 9.37 million shares, slightly below ...

Belén Garijo, who took over the reins of the French pharma group in April, said this morning that Sanofi's "whole ...

While praising the breadth of its pipeline, AstraZeneca has launched a three-year cost-cutting programme that will aim to ...

Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms ...

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. Francisco Partners is ...

The US federal government has awarded $99 million in funding for a one-shot vaccine against the Bundibugyo virus (BDBV), the ...

Dren Bio has closed a sizeable private financing round, raising $350 million to fund pivotal trials of its potentially ...

Among the highlights of UK Chancellor John Healey's first Budget was more than £1 billion in investment by Convatec, Vertex ...

Eli Lilly has added another arrow to the quiver of its new diabetes and weight-loss therapy retatrutide, comprehensively ...

Switzerland's Ferring Pharma has reached an agreement to buy US women's health startup Gameto for up to $1.38 billion, ...

While Anthropic has not disclosed the number of shares to be released, their price range, or a date for the listing, ...

AbbVie has filed for FDA approval of its T-cell engager (TCE) etentamig in relapsed or refractory multiple myeloma, a key ...